1031335-28-0

Basic information

• Product Name: 5-Amino-hexahydro-cyclopenta[c]pyrrole-2-carboxylic acid tert-butyl ester
• Synonyms: 5-Amino-hexahydro-cyclopenta[c]pyrrole-2-carboxylic acid tert-butyl ester;Cyclopenta[c]pyrrole-2(1H)-carboxylic acid, 5-aMinohexahydro-, 1,1-diMethylethyl ester;tert-butyl 5-aMinohexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate;tert-Butyl 5-aminohexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate hydrochloride
• CAS NO: 1031335-28-0
• Molecular Formula: C12H20N2O2
• Molecular Weight: 224
• EINECS: 604-604-1
• Mol File: 1031335-28-0.mol
• Article Data: 19

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 5-Amino-hexahydro-cyclopenta[c]pyrrole-2-carboxylic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Amino-hexahydro-cyclopenta[c]pyrrole-2-carboxylic acid tert-butyl ester(1031335-28-0)
• EPA Substance Registry System: 5-Amino-hexahydro-cyclopenta[c]pyrrole-2-carboxylic acid tert-butyl ester(1031335-28-0)

Safety Data

• Hazardous Substances Data: 1031335-28-0(Hazardous Substances Data)

Usage

General Description

The chemical 5-Amino-hexahydro-cyclopenta[c]pyrrole-2-carboxylic acid tert-butyl ester, also known as AHPCP-TBOC, is a tert-butyl ester derivative of a cyclopentapyrrole carboxylic acid. It is a compound with potential applications in pharmaceutical and chemical research, such as in the development of new drugs or as a building block in organic synthesis. The presence of an amino group and a cyclic structure in AHPCP-TBOC makes it a versatile building block for constructing complex molecules. Its tert-butyl ester form also provides protection for the carboxylic acid functionality, which can be selectively removed under specific conditions to reveal the free acid for further chemical modifications and synthetic processes. Overall, 5-Amino-hexahydro-cyclopenta[c]pyrrole-2-carboxylic acid tert-butyl ester is a valuable chemical compound with potential applications in various research and development fields.

Upstream product

• 863600-79-7 tert-butyl (cis-exo)-5-(benzylamino)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxylate 
• 146231-54-1 (3aR,6aS)-tert-butyl 5-oxohexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate 
• 147528-20-9 N-(tert-butoxycarbonyl)-N-allyl-3-amino-1-propyne 
• 42268-68-8 allylpropargylamine 
• 148404-28-8 tert-butyl 5-oxohexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate 
• 1256039-48-1 tert-butyl (3aR,5s,6aS)-5-azido-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxylate 
• 912563-48-5 tert-butyl (3aR,5r,6aS)-5-hydroxy-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxylate 
• 912563-45-2 tert-butyl (3aR,5r,6aS)-5-hydroxy-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxylate 
• 10533-30-9 2,3,3a,4,7,7a-hexahydro-1H-isoindole 
• 85-40-5 1,2,3,6-tertahydrophthalimide 

Downstream Products

• 1217315-33-7 C₂₄H₃₅FN₂O₃ 
• 1217315-34-8 C₂₂H₃₄N₂O₃ 
• 1217315-35-9 C₂₄H₃₆N₂O₃ 
• 1416329-44-6 (3aR,5S,6aS)-tert-butyl 5-(methylamino)hexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate 
• 1416329-43-5 rac-cis-dihydrogen-2-boc-octahydro-cyclopcnta[c]pyrroic-5-ylamine 

Relevant articles and documents

JAK KINASE INHIBITOR, PREPARATION METHOD FOR SAME, AND APPLICATIONS THEREOF IN FIELD OF MEDICINE

-

ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4

Disclosed herein are substituted hexahydro-1H-cyclopenta[c]pyrrole compounds, which may be useful as antagonists of the muscarinic acetylcholine receptor M4 (mAChR M4). Also disclosed herein are methods of making the compounds, pharmaceutical compositions comprising the compounds, and methods of treating disorders using the compounds and compositions.

ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4

Disclosed herein are 2,3,5-trifluorophenyl-pyridazine substituted hexahydro-1H- cyclopenta[c]pyrrole compounds, useful as antagonists of the muscarinic acetylcholine receptor M4 (mAChR M4) Also disclosed herein are methods of making the compounds, pharmaceutical compositions comprising the compounds, and methods of treating disorders using the compounds and compositions.